<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0049">
 <label>49</label>
 <mixed-citation publication-type="journal" id="CIT0049-gen-2">(a) 
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Roldán-Peña</surname>
    <given-names>JM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Romero-Real</surname>
    <given-names>V</given-names>
   </name>, 
   <name name-style="western">
    <surname>Hicke</surname>
    <given-names>J</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer’s disease: selective subnanomolar BuChE inhibitors</article-title>. 
  <source>Eur J Med Chem</source>
  <year>2019</year>;
  <volume>181</volume>:
  <fpage>111550</fpage>.
  <pub-id pub-id-type="pmid">31376562</pub-id>
 </mixed-citation>
 <mixed-citation publication-type="journal" id="CIT0049-gen-3">(b) 
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Roldán-Peña</surname>
    <given-names>JM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Alejandre-Ramos</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>López</surname>
    <given-names>Ó</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>New tacrine dimers with antioxidant linkers as dual drugs: anti-Alzheimer’s and antiproliferative agents</article-title>. 
  <source>Eur J Med Chem</source>
  <year>2017</year>;
  <volume>138</volume>:
  <fpage>761</fpage>–
  <lpage>73</lpage>.
  <pub-id pub-id-type="pmid">28728108</pub-id>
 </mixed-citation>
</ref>
